35 results
DEFM14A
ORTX
Orchard Therapeutics plc
16 Nov 23
Proxy related to merger
4:45pm
in workforce aligned with such changes, on such timeline as Orchard management deemed to be in Orchard’s best interest.
The Orchard Board also considered … workforce by approximately 30%.
On May 16, 2022, representatives of KKC presented a high-level outline of a potential framework for a research
PREM14A
ORTX
Orchard Therapeutics plc
3 Nov 23
Preliminary proxy related to merger
5:11pm
with a reduction in workforce aligned with such changes, on such timeline as Orchard management deemed to be in Orchard’s best interest.
The Orchard … for Orchard to reduce its workforce by approximately 30%.
On May 16, 2022, representatives of KKC presented a high-level outline of a potential framework
DEFA14A
ORTX
Orchard Therapeutics plc
5 Oct 23
Additional proxy soliciting materials
9:07am
or implemented any workforce reductions or terminations, with a stated rationale of being in response to the impact of the COVID-19 pandemic.
(j) Neither
8-K
EX-2.1
ORTX
Orchard Therapeutics plc
5 Oct 23
Kyowa Kirin to Acquire Orchard Therapeutics
9:05am
or wages, annual bonus targets or amounts or commissions, nor delayed or deferred payment of any of the foregoing or implemented any workforce
8-K
EX-99.1
xwkocniiy6mijyp
4 Aug 22
Orchard Therapeutics Reports Second Quarter 2022 Financial Results and Reviews Recent Business Highlights
7:05am
8-K
EX-99.1
5zyhqhjiwiiss6w
12 May 22
Orchard Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Commercial Progress
7:05am
8-K
EX-99.1
x481x
30 Mar 22
Results of Operations and Financial Condition
7:40am